Strategic investments, workforce readiness, and pioneering initiatives are attracting leading life sciences companies to ...

A major pharmaceutical company that has invested heavily in North Carolina is ... Elsewhere in the state, Eli Lilly has invested heavily in a manufacturing campus in Concord.

Eli Lilly has also said that a new plant in Concord, North Carolina, will start production of incretin drugs as early as the end of the year, with products available to ship in 2025. The company ...

Indianapolis-based pharmaceutical giant Eli Lilly and Co. announced plans ... announced new sites at Research Triangle Park in Concord, North Carolina, and the acquisition and expansion of its ...

Eli Lilly has raised its revenue guidance ... In its update, Ricks said a new facility at Concord in North Carolina – part of an $18 billion investment programme launched in 2020 – is being ...

Eli Lilly reported earlier this year that it was expanding its production capacity for its weight loss drugs, having committed $1 billion for a new manufacturing site in Concord, North Carolina.

Eli Lilly wants the most optimal ... among biopharmaceuticals companies, such as North Carolina and Wisconsin, are also getting investments from Lilly. The four new sites being devised will ...

Healthcare & Pharmaceuticalscategory· March 21, 2025 Eli Lilly launches weight-loss drug ... March 11, 2025 Merck opens manufacturing facility in North Carolina amid Trump's tariff threats ...